RELATED: CDC panel endorses Pfizer COVID-19 vaccine for children 12 and upThe researchers found that only 16.5% of children studied developed respiratory problems, despite the fact COVID-19 is considered a respiratory disease.
What’s more, only 18.8% of the pediatric patients reported symptoms such as muscle aches, joint pain, general malaise and the loss of taste or smell — the last of which has become a tell-tale sign of coronavirus infection, mainly in adults.
Meanwhile, gastrointestinal symptoms such as nausea, vomiting and diarrhea were found among 13.9% of the pediatric patients, while headaches and other neurological symptoms occurred in less than 5% of the children studied.